1740 – N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP) to aid in the diagnosis of patients with suspected heart failure in a non-hospital setting

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Closed
  • Outcome Supported

Application details

Reason for application

New MBS item

Service or technology in this application

A blood test (NT-proBNP assay), requested by a cardiologist to determine the level of cardiac neurohormone in the blood of a patient with a suspected heart failure. The result of the test informs subsequent treatment.

Type: Investigative technology

Medical condition this application addresses

Heart failure occurs when the heart muscle does not pump blood as well as it should. The result is that blood often backs up and fluid can build up in the lungs, causing shortness of breath.

Consultation survey and deadlines

  • PASC consultation: Closed
  • MSAC consultation: Closed Friday, 6 October 2023

Meetings to consider this application

  • PASC meeting: 13–14 April 2023
  • ESC meeting: 5–6 October 2023
  • MSAC meeting: 23–24 November 2023